These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15840628)

  • 1. Wrangling prescription drug benefits: a conversation with Express Scripts' Barrett Toan. Interview by Robert F. Atlas.
    Toan B
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-191-W5-198. PubMed ID: 15840628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PBMs in implementing the Medicare prescription drug benefit.
    Atlas RF
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-504-15. PubMed ID: 15513957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seeking value in working with pharmacy benefit managers.
    Vogenberg FR; Sica JM
    Benefits Q; 2003; 19(1):7-12. PubMed ID: 12608113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spotlight on PBMs: federal enforcement of the anti-kickback statute on the pharmaceutical benefit management industry.
    Radinsky G
    J Health Law; 2003; 36(2):213-46. PubMed ID: 12940677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the PBM in total health management strategies for individuals with chronic conditions.
    Slezak J; Stine N
    Benefits Q; 2003; 19(1):38-44. PubMed ID: 12608117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead.
    Seeley E; Kesselheim AS
    Issue Brief (Commonw Fund); 2019 Mar; 2019():1-11. PubMed ID: 30990594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription or proscription? The general failure of attempts to litigate and legislate against PBMS as "fiduciaries," and the role of market forces allowing PBMS to contain private-sector prescription drug prices.
    O'Donnell TP; Fendler MK
    J Health Law; 2007; 40(2):205-40. PubMed ID: 17849828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebates and spreads: pharmacy benefit management practices and corporate citizenship.
    Rentmeester CA; Garis RI
    J Health Polit Policy Law; 2008 Oct; 33(5):943-63; discussion 965-978. PubMed ID: 18818428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBMs to the rescue? Pharmacy benefit managers will play a key role in the Medicare drug benefit. What does it mean for the industry, consumers and Uncle Sam?
    Fong T
    Mod Healthc; 2005 Nov; 35(48):26-8, 30. PubMed ID: 16617721
    [No Abstract]   [Full Text] [Related]  

  • 10. Unraveling the ramifications of recent pharmaceutical industry acquisitions by looking at the past, present and future of PBMs (pharmacy benefit management firms).
    Herzfeld JD
    Empl Benefits J; 1995 Mar; 20(1):20-3, 30. PubMed ID: 10142515
    [No Abstract]   [Full Text] [Related]  

  • 11. Accounting principles, revenue recognition, and the profitability of pharmacy benefit managers.
    McLean RA; Garis RI
    Res Social Adm Pharm; 2005 Mar; 1(1):118-25. PubMed ID: 17138469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conversation with Debra Dullinger, PharmD.
    Dullinger D
    Med Interface; 1994 Oct; 7(10):71-4. PubMed ID: 10137568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part D implementation: how did health plans fare? A conversation with Stan Nowak, founder, president, and chief executive officer of Silverlink Communications. Interview by William Atkinson.
    Nowak S
    AHIP Cover; 2006; 47(4):46, 49, 51. PubMed ID: 16894854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug utilization: using objective data to achieve cost-efficiency.
    Eber BL
    Benefits Q; 2005; 21(1):7-13. PubMed ID: 15825631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing a pharmacy benefits manager. The shadowlands of PBMs. Seek out the experts to navigate the gray territory of drug-benefits managing.
    Becker C
    Mod Healthc; 2004 Nov; 34(45):S4. PubMed ID: 15560637
    [No Abstract]   [Full Text] [Related]  

  • 17. The new Medicare prescription drug benefit: important issues for physician practices.
    Falk R; Stranne S
    J Med Pract Manage; 2005; 21(3):133-7. PubMed ID: 16471382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grasping the role of technology: a conversation with Ron Dollens. Interview by John K. Iglehart.
    Dollens R
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-296-W5-313. PubMed ID: 15975988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy Benefit Managers in the Eye of the Storm: Growing Multipartite Scrutiny.
    Adashi EY; O'Mahony DP; Guzick DS
    J Am Board Fam Med; 2024 Jan; 36(6):1065-1067. PubMed ID: 38171579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should drug prices be negotiated under part D of Medicare? And if so, how?
    Frank RG; Newhouse JP
    Health Aff (Millwood); 2008; 27(1):33-43. PubMed ID: 18180478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.